Swierkot J - Search Results

1

[The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part II. Tocilizumab, Abatacept, Rituximab--drugs characterised by a different mechanism of action than TNF-alpha inhibitors].

Swierkot J, Madej M. Swierkot J, et al. Pol Merkur Lekarski. 2011 Apr;30(178):289-94. Pol Merkur Lekarski. 2011. PMID: 21595177 Review. Polish.

2

[Rheumatic disorders in diabetes mellitus].

Swierkot J, Gruszecka-Marczyńska K, Sowiński D, Szechiński J. Swierkot J, et al. Pol Merkur Lekarski. 2005 Dec;19(114):843-7. Pol Merkur Lekarski. 2005. PMID: 16521438 Review. Polish.

3

Methotrexate in rheumatoid arthritis.

Swierkot J, Szechiński J. Swierkot J, et al. Pharmacol Rep. 2006 Jul-Aug;58(4):473-92. Pharmacol Rep. 2006. PMID: 16963793 Free article. Review.

4

[The importance of pharmacogenetic tests in evaluation of the effectiveness of methotrexate treatment in rheumatoid arthritis (part 1)].

Swierkot J, Slęzak R. Swierkot J, et al. Postepy Hig Med Dosw (Online). 2011 Mar 30;65:195-206. doi: 10.5604/17322693.936689. Postepy Hig Med Dosw (Online). 2011. PMID: 21502696 Free article. Polish.

5

[The importance of pharmacogenetic tests in evaluation of the effectiveness of methotrexate treatment in rheumatoid arthritis (part 2)].

Swierkot J, Slęzak R. Swierkot J, et al. Postepy Hig Med Dosw (Online). 2011 Mar 30;65:207-15. doi: 10.5604/17322693.936691. Postepy Hig Med Dosw (Online). 2011. PMID: 21502697 Free article. Polish.

6

[The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part I. Tumor necrosis factor alpha inhibitors].

Swierkot J, Madej M. Swierkot J, et al. Pol Merkur Lekarski. 2011 Apr;30(178):283-8. Pol Merkur Lekarski. 2011. PMID: 21595176 Review. Polish.

7

[The role of intravenous immunoglobulin in the treatment of rheumatic diseases in adults].

Swierkot J, Lewandowicz-Uszyńska A. Swierkot J, et al. Pol Merkur Lekarski. 2011 Jun;30(180):435-40. Pol Merkur Lekarski. 2011. PMID: 21751555 Review. Polish.

8

[Practical comments on the use of immunoglobulins].

Lewandowicz-Uszyńska A, Swierkot J. Lewandowicz-Uszyńska A, et al. Among authors: swierkot j. Pol Merkur Lekarski. 2011 Jun;30(180):448-51. Pol Merkur Lekarski. 2011. PMID: 21751557 Review. Polish.

9

Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis.

Swierkot J, Bogunia-Kubik K, Nowak B, Bialowas K, Korman L, Gebura K, Kolossa K, Jeka S, Wiland P. Swierkot J, et al. Joint Bone Spine. 2015 Mar;82(2):94-9. doi: 10.1016/j.jbspin.2014.08.006. Epub 2014 Oct 11. Joint Bone Spine. 2015. PMID: 25311255

10

Activity of JAK/STAT and NF-kB in patients with axial spondyloarthritis.

Świerkot J, Sokolik R, Czarny A, Zaczyńska E, Nowak B, Chlebicki A, Korman L, Madej M, Wojtala P, Lubiński Ł, Wiland P. Świerkot J, et al. Postepy Hig Med Dosw (Online). 2015 Dec 2;69:1291-8. doi: 10.5604/17322693.1184460. Postepy Hig Med Dosw (Online). 2015. PMID: 26671920 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters